| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 10/10/2002 | CA2441077A1 Substituted carbazoles as inhibitors of spla2 |
| 10/10/2002 | CA2406832A1 Preventives/remedies for alzheimer's disease |
| 10/09/2002 | EP1247803A2 Indolinone compounds suitable for modulation of protein kinases |
| 10/09/2002 | EP1246819A1 A method for the preparation of substituted benzene derivatives |
| 10/09/2002 | EP1246818A1 Novel indole derivatives |
| 10/09/2002 | EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 10/09/2002 | EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 10/09/2002 | EP1246815A1 Phenylpiperazinyl derivatives |
| 10/09/2002 | EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists |
| 10/09/2002 | EP1246795A2 Antibacterial agents |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/09/2002 | EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels |
| 10/09/2002 | EP1000025A4 Substituted naphthopyrans |
| 10/09/2002 | EP0946542B1 Indane or dihydroindole derivatives |
| 10/09/2002 | CN1373754A Antibacterial agents |
| 10/09/2002 | CN1092193C Prolylendopeptidase inhibitors |
| 10/08/2002 | US6462234 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide |
| 10/08/2002 | US6462207 Which upon further chemical modification are useful in biomedical applications, permit the synthesis of new polymers, may be used as intermediates in the preparation of compositions possessing properties of interest |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6462056 Oxazolidines as 5-HT2A-antagonists |
| 10/08/2002 | US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents |
| 10/08/2002 | US6462032 Cyclic regimens utilizing indoline derivatives |
| 10/03/2002 | WO2002076988A2 Tert. alkylphenoxy substituted polycyclic compounds |
| 10/03/2002 | WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 10/03/2002 | WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | WO2000034265A3 Quinoline-indole antimicrobial agents |
| 10/03/2002 | WO1998008787A3 Resolution of racemic mixtures using polymers containing chiral units |
| 10/03/2002 | US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 10/03/2002 | US20020143046 Used as calcium channel blockers |
| 10/03/2002 | US20020143045 Reacting 4-(oxiran-2-ylmethoxy)-9H- carbazole with 2-(2-methoxyphenoxy)ethylamine to produce carvedilol |
| 10/03/2002 | US20020143036 Pentafluorobenzenesulfonamides and analogs |
| 10/03/2002 | US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
| 10/02/2002 | EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/02/2002 | EP1245229A2 Methods and compositions for inhibition of angiogenesis |
| 10/02/2002 | EP1244626A2 Caspase inhibitors and uses thereof |
| 10/02/2002 | EP1244621A1 Nitrile derivatives as cathepsin k inhibitors |
| 10/02/2002 | EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| 10/02/2002 | EP0917529A4 Catalyst compositions and processes for olefin oligomerization and polymerization |
| 10/02/2002 | EP0843675B1 Aza-anthracyclinone derivatives |
| 10/02/2002 | EP0706521B1 Imides as tnf alpha inhibitors |
| 10/02/2002 | EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring |
| 10/02/2002 | DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility |
| 10/02/2002 | CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases |
| 10/02/2002 | CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands |
| 10/02/2002 | CN1372545A 吲哚衍生物 Indole derivatives |
| 10/01/2002 | US6458985 Use of compressed CO2 in chemical reactions |
| 10/01/2002 | US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458824 Solid preparation |
| 10/01/2002 | US6458806 Aryl alkenamides derivatives as MCP-1 antagonists |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458781 Blockers calcium channel antagonists for strokes, brain disorders |
| 10/01/2002 | US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity |
| 10/01/2002 | CA2209018C Sulfonamides and their use |
| 10/01/2002 | CA2059708C Indole derivatives |
| 09/26/2002 | WO2002074764A2 Piperazine derivatives and their use as 5-ht1b ligands |
| 09/26/2002 | WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility |
| 09/26/2002 | WO2002074740A1 Biguanide derivatives |
| 09/26/2002 | WO2002074342A1 Remedies for arteriosclerosis |
| 09/26/2002 | WO2002074309A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors |
| 09/26/2002 | WO2002074306A1 Remedies for fatty liver |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002055517A3 4-(hetero)aryl substituted indolinones |
| 09/26/2002 | WO2002038544A3 3-substituted oxindole beta 3 agonists |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002003975A3 Combinations of ssri and estrogenic agents |
| 09/26/2002 | WO2001091756A3 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 09/26/2002 | WO2000043375A3 Substituted aryl heterocyclic compounds |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137929 1 - (3-heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents |
| 09/26/2002 | US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 09/26/2002 | US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137201 Detection of transmembrane potentials by optical methods |
| 09/25/2002 | EP1242471A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | EP1242376A1 Method for producing oxindoles |
| 09/25/2002 | EP1242375A2 Method for purifying lactames |
| 09/25/2002 | EP1242366A1 Salicylamides as serine protease and factor xa inhibitors |
| 09/25/2002 | EP1242360A2 Exciplexes |
| 09/25/2002 | EP1242327A1 Pigmented vitreous material its precursor glass items coated therewith and method of its preparation |
| 09/25/2002 | EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 09/25/2002 | EP1242081A1 Caspases and apoptosis |
| 09/25/2002 | EP1242074A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists |
| 09/25/2002 | EP1242069A2 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 09/25/2002 | EP0976731B1 Process for producing 5-methylindolines |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/24/2002 | US6455709 Such as 1,3-dimethyl-fulleropyrrolidine-1,3-dicarboxylic n-amide oligomer |